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Background: According to recommendations, non-invasive monitoring during neonatal
resuscitation after birth includes heart rate (HR) and oxygen saturation (SpO2).
Continuous transcutaneous monitoring of carbon dioxide partial pressure (tcpCO2) may
further offer quantitative information on neonatal respiratory status.
Objective: We aimed to investigate feasibility of tcpCO2 measurements in the delivery
room during immediate neonatal transition and to compare the course of tcpCO2
between stable term and preterm infants.
Methods: Neonates without need for cardio-respiratory intervention during immediate
transition after birth were enrolled in a prospective observational study. In these term
and preterm neonates, we measured HR and SpO2 by pulse oximetry on the right
wrist and tcpCO2 with the sensor applied on the left hemithorax during the first 15min
after birth. Courses of tcpCO2 were analyzed in term and preterm neonates and groups
were compared.
Results: Fifty-three term (gestational age: 38.8 ± 0.9 weeks) and 13 preterm neonates
(gestational age: 34.1 ± 1.5 weeks) were included. First tcpCO2 values were achieved
in both groups at minute 4 after birth, which reached a stable plateau after the
equilibration phase at minute 9. Mean tcpCO2 values 15min after birth were 46.2 (95%
CI 34.5–57.8)mmHg in term neonates and 48.5 (95%CI 43.0–54.1) mmHg in preterm
neonates. Preterm and term infants did not show significant differences in the tcpCO2
values at any time point.
Conclusion: This study demonstrates that tcpCO2 measurement is feasible during
immediate neonatal transition after birth and that tcpCO2 values were comparable in
stable term and preterm neonates.
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INTRODUCTION
Neonatologist are confronted with the complexity of monitoring
transition from intra- to extra-uterine life. It is a multi-step event,
characterized by rapid physiological changes in respiratory,
cardio-circulatory and metabolic status.
The decrease in partial pressure of oxygen and the increase in
that of carbon dioxide (pCO2) followed by respiratory acidosis
is one of the main triggers for initiation of breathing (1). After
proper and effective establishment of respiratory function, the
exchange of CO2 and O2 should reach a steady state.
To date, there are different methods and devices to assess
oxygenation and cardio-circulatory status during neonatal
transition. The most widespread monitoring is pulse oximetry,
a non-invasive mode to detect heart rate (HR) and peripheral
oxygen saturation (SpO2). It is recommended as standard
practice in the delivery room (DR) by current international
guidelines (2). Reference values for both parameters during
immediate transition are available (3, 4).
Although gas exchange problems may be frequent events
during immediate post-natal transition, there is currently no
evidence on the role of CO2 and continuous pCO2 monitoring in
the DR. Moreover, uncertainty remains about its feasibility and
reliability in this setting.
In this study we aimed to evaluate the feasibility of
transcutaneous pCO2 (tcpCO2) monitoring in stable neonates
during the first 15min after birth. Moreover, we compared
tcpCO2 values between term and preterm neonates without need
for any intervention immediately after birth. We hypothesized
that tcpCO2 monitoring during immediate transition after birth
is feasible and that term and preterm neonates differ in tcpCO2
during this phase.
METHODS
A prospective observational study was conducted from October
2015 to June 2018 at the Division of Neonatology, Department
of Pediatrics and Adolescent Medicine, Medical University of
Graz, Austria. Institutional ethical approval (EC number: 27-
465 ex 14/15) and written parental consent were obtained before
inclusion. Term and preterm neonates born by cesarean section
without any intervention immediately after birth were included
in the study. Exclusion criteria for this analysis were congenital
malformations and/or need for cardio-respiratory support.
Monitoring was performed during the first 15min after birth.
As soon as the neonate was placed on the resuscitation table
in supine position, a pulse oximeter probe was applied on the
right wrist and HR and SpO2 were measured using the IntelliVue
MP50 monitor (Philips, The Netherlands). The tcpCO2 sensor
(TC Sensor 84, Radiometer RSCH GmbH, Thalwil, Switzerland)
was applied on the infant’s left hemithorax and values were
displayed on a separate monitor (IntelliVue MP70, Philips, The
Netherlands). In accordance with the manufacturer’s guidelines,
Abbreviations: HR, heart rate; NICU, neonatal intensive care unit; SpO2, arterial
oxygen saturation; tcpCO2, transcutaneous monitoring of carbon dioxide partial
pressure; DR, delivery room.
the sensor’s temperature was set at 39◦C, the lowest level for
tcpCO2 measurements. The fixation of the tcpCO2 sensor was
observed continuously and data were only recorded when the
sensor was in place and remained attached to the skin.
Statistical Analysis
Demographic variables are presented as absolute counts, mean
and standard deviation (SD) or median and interquartile range
(IQR), as appropriate. Comparisons of categorical baseline
characteristics between preterm and term neonates were made
using chi-square test, t-test or Mann Whitney U-test, as
appropriate. tcpCO2, SpO2, and HR data are presented as mean
and 95% confidence interval (95% CI). We investigated tcpCO2,
SpO2, and HR across time within the first 15min using a
linear mixed model with fixed effects for time and gestational
age (preterm vs. term neonates). A first order autoregressive
covariance structure was used. The autoregressive covariance
structure assumes a systematically decreasing correlation with
increasing distance between time points. Therefore, adjacent
time points have the highest correlations. Post-hoc analyses for
differences between groups at each minute were performed
for the comparison of gestational age groups (pre-term vs.
term neonates). A p-value < 0.05 was considered statistically
significant. Statistical analysis was performed using SPSS
Statistics 24.0.0 (IBM, USA).
RESULTS
Out of 197 measured neonates in the DR, this study included
53 term and 13 preterm neonates without any cardio-respiratory
intervention immediately after birth (Table 1).
Transcutaneous pCO2 values were analyzed from minute 4
after birth, which we considered the first proper detection time.
Earlier values were detected in just a few patients; thus, they
were not included in the analysis. Values reached a stable plateau
after the equilibration phase at minute 9. Mean tcpCO2 values
15min after birth were 46.2 (95% CI 34.5–57.8) mmHg in term
neonates and 48.5 (43.0–54.1) mmHg in preterm infants. They
both showed comparable courses of tcpCO2 without significant
differences at any time point (p= 0.812) (Table 2 and Figure 1).
TABLE 1 | Demographic data of term and preterm neonates with tcpCO2
monitoring immediately after birth.
Term infants (n = 53) Preterm infants (n = 13)
Birth weight (g) 3,027 ± 473 1,880 ± 270
Gestational age (weeks) 38.8 ± 0.9 34.1 ± 1.5
Gender (n)
Male 29 (55%) 4 (31%)
Female 24 (45%) 9 (69%)
Apgar score at min 1 9 (9–9) 9 (9–9)
Apgar score at min 5 10 (10–10) 9 (10–10)
Apgar score at min 10 10 (10–10) 10 (10–10)
Umbilical artery pH 7.31 ± 0.04 7.29 ± 0.05
Data are expressed as absolute counts (%) or mean ± SD or median (IQR).
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TABLE 2 | tcpCO2 during the first 15min after birth in term and preterm neonates.
Minute Term infants Preterm infants p-Value
4 12.8 (1.1–24.5) 13.8 (3.5–24.1) 0.752
5 22.4 (10.7–34.0) 25.1 (15.0–35.2) 0.386
6 30.3 (18.6–42.0) 33.5 (23.6–43.4) 0.312
7 35.7 (24.1–47.4) 39.5 (29.8–49.1) 0.229
8 39.9 (28.3–51.6) 43.8 (34.4–53.3) 0.208
9 42.7 (31.0–54.3) 46.2 (37.0–55.4) 0.262
10 44.4 (32.8–56.1) 47 (38.1–55.9) 0.409
11 45.7 (34.0–57.3) 47.2 (38.6–55.7) 0.630
12 46.1 (34.5–57.8) 48.1 (39.9–56.3) 0.531
13 46.3 (34.6–58.0) 48.5 (40.7–56.2) 0.487
14 46.4 (34.8–58.1) 48.7 (41.6–55.8) 0.467
15 46.2 (34.5–57.8) 48.5 (43.0–54.1) 0.442
Mean values and 95%CI are presented.
FIGURE 1 | tcpCO2 course during the first 15min after birth in term and
preterm neonates.
SpO2 and HR values were within targets (2), although SpO2
values in preterm neonates were significantly higher at minutes
2, 4, and 5 (in preterm infants at min 2: 75.8, 95% CI: 55.7–
84.9, at min 4: 82.7, 95% CI: 73.9–91.5; at min 5: 87.3 95%CI:
78.6–96.0; in term infants at min 2: 68.7, 95% CI: 60.4–77.0, at
min 4: 78.3, 95% CI: 70.0–86.5, at min 5: 87.3 95% CI: 82.5–
90.8) and HR values were significantly lower at minute 2 (in
preterm infants: 106 bpm, 95% CI: 71.5–141.9; in term infants:
138.3 bpm, 95% CI: 107.4–169.2).
DISCUSSION
To our knowledge, this is the first description of tcpCO2
measurements in term and preterm neonates in the DR
during immediate post-natal transition (5). In this study, we
demonstrated that the use of tcpCO2 monitoring is feasible
and safe.
First values could be obtained rather quickly at minute 4
after birth. We observed a progressive increase of values over
the first minutes, until a plateau was reached at minute 9
after birth. This initial trend of tcpCO2 is attributed to the
equilibration phase of the skin sensor which is necessary to obtain
reliable values.
As we only enrolled neonates who did not require
cardio-respiratory intervention and completed post-natal
transition in a physiological way, it is reasonable to assume
that the observed tcpCO2 values reflect uncompromised
neonatal transition.
The importance of pCO2 levels in neonates is well-known.
In fact, evidence clearly shows that pCO2 strongly influences
cerebral perfusion in newborn infants, especially in those of low
gestational age (6), and its uncontrolled increase may lead to
brain injury.Moreover, the fact that blood gas values change quite
rapidly has raised interest for continuous monitoring of pCO2
(7). Therefore, invasive and non-invasive pCO2 monitoring is
widely used in neonates admitted to neonatal intensive care units
(NICU). Two non-invasive methods for pCO2 monitoring are
available: the transcutaneous measurement and the exhaled or
end-tidal CO2 (etCO2) measurement (8, 9). They both provide
continuous estimation of pCO2 and they significantly reduce
blood samples, which is particularly important in neonates.
However, they also have some limitations mainly due to
technical reasons.
EtCO2 monitoring during immediate transition has shown
valuable results in neonates needing respiratory support (10)
but its use is limited to ventilated patients. It reflects the
efficacy of lung aeration and the establishment of effective
V/Q match in the first minutes after birth and it seems to be
a promising instrument in the DR more to confirm correct
endotracheal tube placement or to verify the efficacy of mask
ventilation (5). However, it is not that accurate in providing
information on arterial pCO2 levels when neonates experience
respiratory distress. This condition, peculiar of preterm infants,
leads to poor pulmonary perfusion and compromises gas
exchange. Therefore, the etCO2 device may underestimate high
arterial pCO2 levels. Transcutaneous pCO2 might overcome this
limitation and, if combined with etCO2, could contribute to a
more reliable estimation of respiratory gas imbalances also in
ventilated patients.
Of note, reference ranges for etCO2 in neonates during
post-natal transition without resuscitation have been proposed
recently (11).
Transcutaneous pCO2 monitoring is used in neonates during
NICU care and relies on the fact that CO2 propagates through
tissue and can be measured by a skin sensor. However, the
correlation between tcpCO2 and blood pCO2 is related to the
perfusion of the capillary bed, so heating of the skin sensor is
required. However, this may cause skin burns. On the other side,
the use of low sensor temperature has been correlated to an
overestimation of the pCO2 (12).
In this study, no skin burns or other adverse reactions
were observed, mainly due to the short measurement period
in the DR, reducing the exposure of neonatal skin to high
sensor temperatures.
This study also demonstrated that there was no difference
between stable term and preterm neonates in regard to tcpCO2
courses and values during the first 15min. The inclusion of
neonates without need for cardio-respiratory support regardless
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of gestational age could in part explain this observation, even if
these two populations are known to differ significantly in HR and
SpO2 values during immediate transition, as also shown by our
findings (3).
The present study has some limitations. First, we attributed
the initial increase to the equilibration phase of the sensor. The
current data set does not allow to differentiate exactly between
equilibration of temperature, microcirculation and pCO2 of the
tissue at the sensor site and true changes in arterial blood of the
neonate. However, according the manufacturer’s equilibration
time and the observed increase of tcpCO2 to a stable plateau at
minute 9 it can be assumed that thereafter tcpCO2 corresponds
to pCO2 in the blood. Furthermore, even if this delay in
acquisition of data cannot currently be avoided, gathering reliable
data within 10min after birth may still be helpful to guide
medical DR interventions. Second, we did not compare tcpCO2
values and those measured from blood samples in the present
analyses of neonates without any intervention. Since there is
controversial evidence in this regard (13–15), this aspect warrants
further investigation.
CONCLUSION
Non-invasive measurement of tcpCO2 seems to be feasible
during immediate neonatal transition, even if measurements in
the very first minutes after birth remain challenging. Further
research is desirable to confirm our results and to investigate
any clinical impact of additional tcpCO2 measurements on DR
interventions in neonates with adverse conditions during the
transitional period.
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